Columbia Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Columbia Asset Management's VRTX Position: Q1 2026 in Review
Columbia Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 29% in Q1 2026, buying an estimated $301K and bringing the position to 2,889 shares worth $1.29M. The position accounts for 0.25% of the portfolio, ranked #77.
Columbia Asset Management first reported a position in VRTX in Q4 2024 and has held it in 5 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Columbia Asset Management held 2,889 shares of Vertex Pharmaceuticals worth $1.29M as of Q1 2026.
- Columbia Asset Management bought 646 Vertex Pharmaceuticals shares in Q1 2026, an estimated $301K.
- Vertex Pharmaceuticals made up 0.25% of Columbia Asset Management's portfolio in Q1 2026, its #77 holding.
- Columbia Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Columbia Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.